by Tina Damalas | Sep 30, 2016
In Malawi, innovative models have been developed to optimize the efficiency of HIV service delivery in order to scale up access to treatment. In particular, three key models of differentiated care have emerged: multi-month prescriptions; fast-track drug refills; and...
by Tina Damalas | Sep 22, 2016
Aurobindo Pharma Limited is pleased to announce the tentative approval of Dolutegravir 50mg from US Food & Drug Administration (USFDA) for the treatment of HIV. This important milestone marks the first FDA approval of a generic version of Dolutegravir (DTG), an...
by Tina Damalas | Sep 14, 2016
The Clinton Health Access Initiative, Inc. (“CHAI”) was founded in 2002 as a Clinton Foundation Initiative. Today, the CHAI Board of Directors, which is fully committed to and proud of CHAI’s life-saving work, announced the following changes will be implemented if...
Recent Comments